Grant Number:	1R01CA093435-01 Interpret this number
Primary Investigator:	Goldie, Sue
Organization:	Harvard University (Sch Of Public Hlth)
Project Title:	Clinical & Cost-Effectiveness of Cervical CA Screening
Fiscal Year:	2002

DESCRIPTION (provided by applicant): Cervical cancer is the third most common malignancy in women worldwide. New information on the causal role of human papillomavirus (HPV) infection, and the availability of new cervical cancer screening options, raise important clinical and policy questions. The purpose of this project is to develop a Global Cervical Cancer Policy Model to address such questions in both developed and developing countries, in which differences in disease burden, health-care priorities, and economic resources will mandate consideration of different cancer control strategies. In the U.S., cervical cytology screening has reduced cancer incidence, however, has not been equally accessible to all groups of women. For women who are older, poor, or from select cultural minorities, there is a need to evaluate new strategies for increasing screening coverage. On the national level, the most pressing policy questions relate to the economic consequences of current screening programs and how to best utilize newer screening technologies, such as enhanced cytologic methods and HPV DNA testing. In developing countries, such as South and East Africa, the critical policy issue is how to realistically implement cervical cancer screening programs in the setting of competing health issues and limited healthcare and monetary resources. Recent clinical studies have shown promising results for less complex screening strategies, such as simple visual screening methods or HPV DNA testing followed by immediate treatment without colposcopic triage However, these noncytological screening strategies need to be formally evaluated to determine if they can be implemented and sustained for a cost acceptable to developing countries. The specific aims of this project are: (1) To develop a probabilistic cervical cancer model incorporating new epidemiological data on the natural history of HPV; (2) To evaluate the health and economic consequences of alternative cervical cancer screening strategies in the U.S., focusing on subpopulations at particularly high-risk and readdressing optimal target ages, screening intervals and use of new technology; (3) To assess the cost-effectiveness of alternative cervical cancer screening and prevention strategies for previously unscreened women in South Africa and Zimbabwe, incorporating the impact of REV, and considering the health-infrastructure and per-capita health expenditure in each country. This project will bring together a team of diverse investigators with complementary areas of expertise to develop a comprehensive, state-of-the-art, Global Cervical Cancer Policy Model. The proposed analyses will provide important information to clinicians, public health providers, and policy makers in both the national and international arena.




Health And Economic Impact Of Hpv 16/18 Vaccination And Cervical Cancer Screening In Eastern Africa
Authors: Campos N.G. , Kim J.J. , Castle P.E. , Ortendahl J.D. , O'Shea M. , Diaz M. , Goldie S.J. .
Source: International Journal Of Cancer, 2012-06-01 00:00:00.0; 130(11), p. 2672-84.
PMID: 21717458
Related Citations

Finding Consensus On Cervical Cancer Prevention
Authors: Goldie S.J. , O'Shea M. , Kim J.J. .
Source: American Journal Of Public Health, 2012 Jun; 102(6), p. 1050-1; author reply 1051.
PMID: 22515848
Related Citations

Policy Implications Of Adjusting Randomized Trial Data For Economic Evaluations: A Demonstration From The Ascus-lsil Triage Study
Authors: Campos N.G. , Castle P.E. , Schiffman M. , Kim J.J. .
Source: Medical Decision Making : An International Journal Of The Society For Medical Decision Making, 2012 May-Jun; 32(3), p. 400-27.
PMID: 22147881
Related Citations

Cost-effectiveness Of Cervical Cancer Screening With Primary Human Papillomavirus Testing In Norway
Authors: Burger E.A. , Ortendahl J.D. , Sy S. , Kristiansen I.S. , Kim J.J. .
Source: British Journal Of Cancer, 2012-04-24 00:00:00.0; 106(9), p. 1571-8.
PMID: 22441643
Related Citations

Model-based Analyses To Compare Health And Economic Outcomes Of Cancer Control: Inclusion Of Disparities
Authors: Goldie S.J. , Daniels N. .
Source: Journal Of The National Cancer Institute, 2011-09-21 00:00:00.0; 103(18), p. 1373-86.
PMID: 21900120
Related Citations

Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.
Authors: Campos N.G. , Rodriguez A.C. , Castle P.E. , Herrero R. , Hildesheim A. , Katki H. , Kim J.J. , Wacholder S. , Morales J. , Burk R.D. , et al. .
Source: The Journal Of Infectious Diseases, 2011-03-15 00:00:00.0; 203(6), p. 823-7.
EPub date: 2011-03-15 00:00:00.0.
PMID: 21257737
Related Citations

Effects Of Direct-to-consumer Advertising And Clinical Guidelines On Appropriate Use Of Human Papillomavirus Dna Tests
Authors: Price R.A. , Frank R.G. , Cleary P.D. , Goldie S.J. .
Source: Medical Care, 2011 Feb; 49(2), p. 132-8.
PMID: 21150798
Related Citations

Targeted Human Papillomavirus Vaccination Of Men Who Have Sex With Men In The Usa: A Cost-effectiveness Modelling Analysis
Authors: Kim J.J. .
Source: The Lancet. Infectious Diseases, 2010 Dec; 10(12), p. 845-52.
PMID: 21051295
Related Citations

Empirically Evaluating Decision-analytic Models
Authors: Goldhaber-Fiebert J.D. , Stout N.K. , Goldie S.J. .
Source: Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 2010 Aug; 13(5), p. 667-74.
PMID: 20230547
Related Citations

Cost-effectiveness Of Human Papillomavirus Vaccination And Cervical Cancer Screening In Women Older Than 30 Years In The United States
Authors: Kim J.J. , Ortendahl J. , Goldie S.J. .
Source: Annals Of Internal Medicine, 2009-10-20 00:00:00.0; 151(8), p. 538-45.
PMID: 19841455
Related Citations

Program Spending To Increase Adherence: South African Cervical Cancer Screening
Authors: Goldhaber-Fiebert J.D. , Denny L.A. , De Souza M. , Kuhn L. , Goldie S.J. .
Source: Plos One, 2009; 4(5), p. e5691.
PMID: 19492097
Related Citations

Cost Effectiveness Analysis Of Including Boys In A Human Papillomavirus Vaccination Programme In The United States
Authors: Kim J.J. , Goldie S.J. .
Source: Bmj (clinical Research Ed.), 2009; 339, p. b3884.
PMID: 19815582
Related Citations

Keeping the noise down: common random numbers for disease simulation modeling.
Authors: Stout N.K. , Goldie S.J. .
Source: Health Care Management Science, 2008 Dec; 11(4), p. 399-406.
PMID: 18998599
Related Citations

Trade-offs In Cervical Cancer Prevention: Balancing Benefits And Risks
Authors: Stout N.K. , Goldhaber-Fiebert J.D. , Ortendahl J.D. , Goldie S.J. .
Source: Archives Of Internal Medicine, 2008-09-22 00:00:00.0; 168(17), p. 1881-9.
PMID: 18809815
Related Citations

Health And Economic Implications Of Hpv Vaccination In The United States
Authors: Kim J.J. , Goldie S.J. .
Source: The New England Journal Of Medicine, 2008-08-21 00:00:00.0; 359(8), p. 821-32.
PMID: 18716299
Related Citations

Modeling Cervical Cancer Prevention In Developed Countries
Authors: Kim J.J. , Brisson M. , Edmunds W.J. , Goldie S.J. .
Source: Vaccine, 2008-08-19 00:00:00.0; 26 Suppl 10, p. K76-86.
PMID: 18847560
Related Citations

The Economic Burden Of Noncervical Human Papillomavirus Disease In The United States
Authors: Hu D. , Goldie S. .
Source: American Journal Of Obstetrics And Gynecology, 2008 May; 198(5), p. 500.e1-7.
PMID: 18455524
Related Citations

Cost-effectiveness Of Cervical Cancer Screening With Human Papillomavirus Dna Testing And Hpv-16,18 Vaccination
Authors: Goldhaber-Fiebert J.D. , Stout N.K. , Salomon J.A. , Kuntz K.M. , Goldie S.J. .
Source: Journal Of The National Cancer Institute, 2008-03-05 00:00:00.0; 100(5), p. 308-20.
PMID: 18314477
Related Citations

The Value Of Including Boys In An Hpv Vaccination Programme: A Cost-effectiveness Analysis In A Low-resource Setting
Authors: Kim J.J. , Andres-Beck B. , Goldie S.J. .
Source: British Journal Of Cancer, 2007-11-05 00:00:00.0; 97(9), p. 1322-8.
PMID: 17923869
Related Citations

Multiparameter Calibration Of A Natural History Model Of Cervical Cancer
Authors: Kim J.J. , Kuntz K.M. , Stout N.K. , Mahmud S. , Villa L.L. , Franco E.L. , Goldie S.J. .
Source: American Journal Of Epidemiology, 2007-07-15 00:00:00.0; 166(2), p. 137-50.
PMID: 17526866
Related Citations

Modeling Human Papillomavirus And Cervical Cancer In The United States For Analyses Of Screening And Vaccination
Authors: Goldhaber-Fiebert J.D. , Stout N.K. , Ortendahl J. , Kuntz K.M. , Goldie S.J. , Salomon J.A. .
Source: Population Health Metrics, 2007; 5, p. 11.
PMID: 17967185
Related Citations

Packaging Health Services When Resources Are Limited: The Example Of A Cervical Cancer Screening Visit
Authors: Kim J.J. , Salomon J.A. , Weinstein M.C. , Goldie S.J. .
Source: Plos Medicine, 2006 Nov; 3(11), p. e434.
PMID: 17105337
Related Citations

A Public Health Approach To Cervical Cancer Control: Considerations Of Screening And Vaccination Strategies
Authors: Goldie S. .
Source: International Journal Of Gynaecology And Obstetrics: The Official Organ Of The International Federation Of Gynaecology And Obstetrics, 2006 Nov; 94 Suppl 1, p. S95-105.
PMID: 17276172
Related Citations

Chapter 18: Public Health Policy For Cervical Cancer Prevention: The Role Of Decision Science, Economic Evaluation, And Mathematical Modeling
Authors: Goldie S.J. , Goldhaber-Fiebert J.D. , Garnett G.P. .
Source: Vaccine, 2006-08-31 00:00:00.0; 24 Suppl 3, p. S3/155-63.
PMID: 16950003
Related Citations

Chapter 19: Cost-effectiveness Of Cervical Cancer Screening
Authors: Goldie S.J. , Kim J.J. , Myers E. .
Source: Vaccine, 2006-08-31 00:00:00.0; 24 Suppl 3, p. S3/164-70.
PMID: 16950004
Related Citations

Chapter 21: Modelling The Impact Of Hpv Vaccines On Cervical Cancer And Screening Programmes
Authors: Garnett G.P. , Kim J.J. , French K. , Goldie S.J. .
Source: Vaccine, 2006-08-31 00:00:00.0; 24 Suppl 3, p. S3/178-86.
PMID: 16950005
Related Citations

Estimating The Cost Of Cervical Cancer Screening In Five Developing Countries
Authors: Goldhaber-Fiebert,J.D. , Goldie,S.J. .
Source: Cost Effectiveness And Resource Allocation : C/e, 2006; 4, p. 13.
PMID: 16887041
Related Citations

Cost-effectiveness Of Cervical-cancer Screening In Five Developing Countries
Authors: Goldie S.J. , Gaffikin L. , Goldhaber-Fiebert J.D. , Gordillo-Tobar A. , Levin C. , Mahé C. , Wright T.C. , Alliance for Cervical Cancer Prevention Cost Working Group .
Source: The New England Journal Of Medicine, 2005-11-17 00:00:00.0; 353(20), p. 2158-68.
PMID: 16291985
Related Citations

The Costs Of Reducing Loss To Follow-up In South African Cervical Cancer Screening
Authors: Goldhaber-Fiebert,J.D. , Denny,L.E. , De Souza,M. , Wright,T.C. , Kuhn,L. , Goldie,S.J. .
Source: Cost Effectiveness And Resource Allocation : C/e, 2005-11-15 00:00:00.0; 3, p. 11.
PMID: 16288646
Related Citations

Cost-effectiveness Of Human Papillomavirus Dna Testing In The United Kingdom, The Netherlands, France, And Italy
Authors: Kim J.J. , Wright T.C. , Goldie S.J. .
Source: Journal Of The National Cancer Institute, 2005-06-15 00:00:00.0; 97(12), p. 888-95.
PMID: 15956650
Related Citations

Hpv Communication: Review Of Existing Research And Recommendations For Patient Education
Authors: Anhang R. , Goodman A. , Goldie S.J. .
Source: Ca: A Cancer Journal For Clinicians, 2004 Sep-Oct; 54(5), p. 248-59.
PMID: 15371283
Related Citations

Projected Clinical Benefits And Cost-effectiveness Of A Human Papillomavirus 16/18 Vaccine
Authors: Goldie S.J. , Kohli M. , Grima D. , Weinstein M.C. , Wright T.C. , Bosch F.X. , Franco E. .
Source: Journal Of The National Cancer Institute, 2004-04-21 00:00:00.0; 96(8), p. 604-15.
PMID: 15100338
Related Citations

Cost-effectiveness Of Human Papillomavirus Dna Testing For Cervical Cancer Screening In Women Aged 30 Years Or More
Authors: Goldie S.J. , Kim J.J. , Wright T.C. .
Source: Obstetrics And Gynecology, 2004 Apr; 103(4), p. 619-31.
PMID: 15051550
Related Citations

News Media Coverage Of Human Papillomavirus
Authors: Anhang,R. , Stryker,J.E. , Wright,T.C. , Goldie,S.J. .
Source: Cancer, 2004-01-15 00:00:00.0; 100(2), p. 308-14.
PMID: 14716765
Related Citations

Women's Desired Information About Human Papillomavirus
Authors: Anhang,R. , Wright,T.C. , Smock,L. , Goldie,S.J. .
Source: Cancer, 2004-01-15 00:00:00.0; 100(2), p. 315-20.
PMID: 14716766
Related Citations

A Comprehensive Natural History Model Of Hpv Infection And Cervical Cancer To Estimate The Clinical Impact Of A Prophylactic Hpv-16/18 Vaccine
Authors: Goldie S.J. , Grima D. , Kohli M. , Wright T.C. , Weinstein M. , Franco E. .
Source: International Journal Of Cancer, 2003-10-10 00:00:00.0; 106(6), p. 896-904.
PMID: 12918067
Related Citations

Chapter 15: Public Health Policy And Cost-effectiveness Analysis
Authors: Goldie,S.J. .
Source: Journal Of The National Cancer Institute. Monographs, 2003; (31), p. 102-10.
PMID: 12807953
Related Citations